Viewing Study NCT01055028


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2026-03-11 @ 4:09 PM
Study NCT ID: NCT01055028
Status: TERMINATED
Last Update Posted: 2018-03-26
First Post: 2010-01-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
Sponsor: Stanford University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Angiosarcomas View
None Soft Tissue Sarcoma View
Keywords: